cafepharma news hand selected daily
get news headlines in your inbox each weekday

Zetia

Tagged:

Answering The Vytorin Question

Forbes

Login or register to post comments

Tagged:

Merck dodged Zetia bullet, analysts say

Fierce Pharma

Login or register to post comments

Tagged:

Merck shares rise as Wall Street brushes off study comparing cholesterol drugs Niaspan, Zetia

Yahoo/AP

Login or register to post comments

Tagged:

[video] Cholesterol Drug Battle: Merck vs. Abbott Labs

CNBC

Login or register to post comments

Tagged:

Another Vytorin Mess For Merck

Forbes

Login or register to post comments

Tagged:

Merck Cholesterol Pill Sales May Drop 20% More on Study Finding

Bloomberg

Login or register to post comments

Tagged:

Merck: FDA won't accept its application for combo cholesterol pill including Pfizer's Lipitor

Yahoo/AP

Login or register to post comments

Tagged:

Why The Market's Up, But Merck's Down

CNBC

Login or register to post comments

Tagged:

More Bad News for Vytorin and Zetia?

WSJ Online

Login or register to post comments

Tagged:

Big Pharma’s Latest Tab: $41.5 Million to Settle Vytorin, Zetia Suits

WSJ Online

Login or register to post comments

New on Cafepharma

Funny or interesting conversations reps hear in the field
Overheard in the Field
Keep up with the latest at cafepharma:
follow us on twitter
GE Healthcare IT
HIV Reps
New message boards
Baxter IT
Pacific Pulmonary Services
Pacific Pulmonary Services IT
New message board category
Pharma IT Boards

<a href="http://finance.yahoo.com">Yahoo! Finance</a><br/><a href="http://finance.yahoo.com/q?s=ABT">Quote for ABT</a>